Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment
NCT07306338 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2026-03-27
Summary
This study assesses patient perspectives on the interest in, feasibility, and acceptability of an Integrative Oncology Program for patients at USC NCCC and HC3 Women's Clinic.
Conditions
- Hematopoietic and Lymphatic System Neoplasm
- Malignant Solid Neoplasm
Interventions
- OTHER
-
Non-Interventional Study
Non-interventional study
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
University of Southern California
lead OTHER
Principal Investigators
-
Xiaoyue M Guo · University of Southern California
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-15
- Primary Completion
- 2027-01-31
- Completion
- 2028-01-31
Countries
- United States
Study Locations
More Related Trials
-
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
NCT03189108 ·Status: TERMINATED
-
Evaluation for NCI Surgery Branch Clinical Research Protocols
NCT00001823 ·Status: RECRUITING
-
Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay
NCT02586389 ·Status: RECRUITING
-
Collection of Tissue Samples for Cancer Research
NCT00900198 ·Status: RECRUITING
-
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
NCT02105168 ·Status: UNKNOWN ·Phase: NA
-
Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
NCT05390827 ·Status: RECRUITING
-
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
NCT05600933 ·Status: ENROLLING_BY_INVITATION
-
PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
NCT05697198 ·Status: COMPLETED
-
NANOTECH RCC Biomarkers
NCT02923284 ·Status: COMPLETED
-
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
NCT05819827 ·Status: TERMINATED
-
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
NCT03977402 ·Status: RECRUITING
-
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
NCT00001503 ·Status: COMPLETED
-
A Biomarker Screening Protocol for Participants With Solid Tumors
NCT05891197 ·Status: TERMINATED
-
A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)
NCT00001938 ·Status: COMPLETED
-
Personalized Cancer Care at Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute
NCT03098576 ·Status: COMPLETED
-
Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection
NCT05585684 ·Status: RECRUITING
-
Data Collection, Clinical Care and Interventions in CCR, NCI
NCT00923065 ·Status: ENROLLING_BY_INVITATION
-
"Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.
NCT05818865 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors
NCT00369109 ·Status: COMPLETED
-
Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC
NCT02436772 ·Status: COMPLETED
-
Metastatic Leiomyosarcoma Biomarker Protocol
NCT05653388 ·Status: RECRUITING
-
Collection of Blood From Patients With Cancer
NCT00034216 ·Status: RECRUITING
-
National Cancer Institute "Cancer Moonshot Biobank"
NCT04314401 ·Status: ACTIVE_NOT_RECRUITING
-
Collecting Solid Tumor Tissue to Identify New Treatments
NCT01658917 ·Status: COMPLETED
-
Circulating Tumor Cells in Solid Tumors
NCT03161821 ·Status: COMPLETED